Detection of intratumoral aromatase in breast carcinomas. An immunohistochemical study with clinicopathologic correlation
about
The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancerQuantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breastEpitope characterization of an aromatase monoclonal antibody suitable for the assessment of intratumoral aromatase activityCYP1B1 is not a major determinant of the disposition of aromatase inhibitors in epithelial cells of invasive ductal carcinoma.In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer.Current status of the prognostic molecular biomarkers in breast cancer: A systematic reviewPreparation of a novel antiserum to aromatase with high affinity and specificity: Its clinicopathological significance on breast cancer tissue.What do we know about the mechanisms of aromatase inhibitor resistance?Biological effects of stable overexpression of aromatase in human hormone-dependent breast cancer cells.The development, application and limitations of breast cancer cell lines to study tamoxifen and aromatase inhibitor resistanceCharacterization of the weak estrogen receptor alpha agonistic activity of exemestane.Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesisNew experimental models for aromatase inhibitor resistance.Red wine polyphenols for cancer prevention.Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trialInhibitors of aromatase prevent degradation of the enzyme in cultured human tumour cells.The Role of the Estrogen Pathway in the Tumor Microenvironment.
P2860
Q24802322-64B59C61-161D-4E2D-AAC1-DE58FC3B87B2Q24803037-8CC190C7-39EE-423F-8380-DDB863224B2BQ28472079-A9EBB85E-1E0E-482D-8DDB-B3F4D4A0B54FQ30440774-E728244D-79DB-4696-AF19-FFF924E4E11AQ33468636-5DD33657-D836-4295-9991-8DFB21E8C460Q33598494-1F5C22FB-EDA7-4649-AE4B-D4BA35EC06D7Q33658005-6026E2D6-5F2F-4342-B69C-E4A2EDF3DA67Q35691554-D8E8A2F4-E8DB-4F2D-BD63-35B00DB5C313Q35977952-91C6489B-44F8-4AB1-A458-D26B2F8A7021Q36013029-3F9BD65E-087F-4AAD-A0D6-2E329B5813C1Q36415607-2DD21012-3124-46D4-9CCC-E0C8A33EA3A9Q36700830-62DC2A03-E356-4621-AA4F-6E4ABAA93B95Q36870346-459B40C9-20FA-4018-9E1F-D17FA0477E1CQ37083429-E4F52B8B-7637-4727-B056-2BA2F2A38D0DQ37226579-06716C83-73F4-4BEC-87E0-23A6EB5A3297Q42280424-75252B2F-1388-4B6D-9612-9B4AE15694D5Q49803828-2B1FF636-2254-4823-AC12-5FB598A1AB72
P2860
Detection of intratumoral aromatase in breast carcinomas. An immunohistochemical study with clinicopathologic correlation
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Detection of intratumoral arom ...... clinicopathologic correlation
@ast
Detection of intratumoral arom ...... clinicopathologic correlation
@en
type
label
Detection of intratumoral arom ...... clinicopathologic correlation
@ast
Detection of intratumoral arom ...... clinicopathologic correlation
@en
prefLabel
Detection of intratumoral arom ...... clinicopathologic correlation
@ast
Detection of intratumoral arom ...... clinicopathologic correlation
@en
P2093
P2860
P1476
Detection of intratumoral arom ...... clinicopathologic correlation
@en
P2093
P2860
P304
P407
P577
1992-02-01T00:00:00Z